Literature DB >> 20117138

A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1.

Alyssa Cornall1, Laveena Sharma, Ajantha Solomon, Paul R Gorry, Suzanne M Crowe, Paul U Cameron, Sharon R Lewin.   

Abstract

Efficient isolation of replication-competent virus from plasma of patients infected with HIV-1 is needed to characterize important clinical parameters of virus. However, addition of plasma to in vitro cultures results in clot formation. Blood from HIV-1 infected patients was collected in the presence of three commonly used anticoagulants (ACD, heparin and EDTA) and plasma was isolated. Plasma was then used to infect HIV-1 indicator cell lines (TZM-bl and GHOST) with spinoculation in the presence or absence of additional heparin and positively charged polymers. The presence of additional heparin during inoculation significantly reduced clot formation without affecting the sensitivity of HIV-1 infection in the GHOST cell line. However, heparin reduced the frequency of HIV-1 infection of the TZM-bl cell line. Using plasma from patients with HIV RNA>1000 copies/ml (n=58), the frequency of HIV-1 isolation was 92% in GHOST (n=51) and 54% in TZM-bl (n=26) cell lines. A sensitive method was developed for rapid isolation of infectious HIV-1 from plasma of patients with HIV RNA>1000 copies/ml that includes spinoculation and the addition of heparin during infection of GHOST cells. This technique could be used for rapid evaluation of viral fitness, co-receptor usage or drug resistance without the need for viral amplification. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117138     DOI: 10.1016/j.jviromet.2010.01.010

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors.

Authors:  Vibha Tandon; Pooja Yadav; Souvik Sur; Sheenu Abbat; Vinod Tiwari; Raymond Hewer; Maria A Papathanasopoulos; Rameez Raja; Akhil C Banerjea; Akhilesh K Verma; Shrikant Kukreti; Prasad V Bharatam
Journal:  ACS Med Chem Lett       Date:  2015-08-10       Impact factor: 4.345

2.  Genetic characterization of natural variants of Vpu from HIV-1 infected individuals from Northern India and their impact on virus release and cell death.

Authors:  Sachin Verma; Larance Ronsard; Richa Kapoor; Akhil C Banerjea
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

3.  HIV-1 Vpr redirects host ubiquitination pathway.

Authors:  Sakshi Arora; Sachin Verma; Akhil C Banerjea
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

4.  Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Authors:  Dan H Barouch; James B Whitney; Brian Moldt; Florian Klein; Thiago Y Oliveira; Jinyan Liu; Kathryn E Stephenson; Hui-Wen Chang; Karthik Shekhar; Sanjana Gupta; Joseph P Nkolola; Michael S Seaman; Kaitlin M Smith; Erica N Borducchi; Crystal Cabral; Jeffrey Y Smith; Stephen Blackmore; Srisowmya Sanisetty; James R Perry; Matthew Beck; Mark G Lewis; William Rinaldi; Arup K Chakraborty; Pascal Poignard; Michel C Nussenzweig; Dennis R Burton
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

5.  Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients.

Authors:  Beatrice Macchi; Caterina Frezza; Francesca Marino-Merlo; Antonella Minutolo; Valeria Stefanizzi; Emanuela Balestrieri; Carlotta Cerva; Loredana Sarmati; Massimo Andreoni; Sandro Grelli; Antonio Mastino
Journal:  Pathogens       Date:  2020-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.